Solesence, Inc. Common Stock
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $67.0M
- Price
- $0.95
- % Change (Daily % change from the live per-ticker quote feed.)
- -4.11%
- Volume
- 13.8K
About
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
Quick stats
Shares outstanding70.5M
Computed float18.2M
Float / shares25.8%
Key info
SectorConsumer Defensive
IndustryHousehold & Personal Products
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000883107
Websitehttps://solesence.com
AI Summary
AI-generated1/20
minorneutralearnings
Solésence Reports Second Quarter 2026 Financial Results
Solésence reported Q2 revenue of $15.3 million, down 25% year-over-year, citing tough comparisons against a prior-year product launch and inventory fill.
Gross margin held steady at 31%, but the company swung to a net loss of $158,000 compared to net income of $3.2 million in the prior year.
Adjusted EBITDA for the quarter was $523,000, significantly lower than the prior year's $3.7 million, reflecting the revenue decline.
Red flags
- Revenue declined 25% YoY due to lapping a one-time product launch
- Swing to net loss of $158,000 from prior year net income of $3.2 million
- Company filed a Form NT 10-Q regarding delayed quarterly report filing